Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
The purpose of this study was to use serial imaging to gain insight into the sequence of pathologic events in Alzheimer's disease, and the clinical features associated with this sequence. We measured change in amyloid deposition over time using serial (11)C Pittsburgh compound B (PIB) positron emission tomography and progression of neurodegeneration using serial structural magnetic resonance imaging. We studied 21 healthy cognitively normal subjects, 32 with amnestic mild cognitive impairment and 8 with Alzheimer's disease. Subjects were drawn from two sources--ongoing longitudinal registries at Mayo Clinic, and the Alzheimer's disease Neuroimaging Initiative (ADNI). All subjects underwent clinical assessments, MRI and PIB studies at two time points, approximately one year apart. PIB retention was quantified in global cortical to cerebellar ratio units and brain atrophy in units of cm(3) by measuring ventricular expansion. The annual change in global PIB retention did not differ by clinical group (P = 0.90), and although small (median 0.042 ratio units/year overall) was greater than zero among all subjects (P < 0.001). Ventricular expansion rates differed by clinical group (P < 0.001) and increased in the following order: cognitively normal (1.3 cm(3)/year) < amnestic mild cognitive impairment (2.5 cm(3)/year) < Alzheimer's disease (7.7 cm(3)/year). Among all subjects there was no correlation between PIB change and concurrent change on CDR-SB (r = -0.01, P = 0.97) but some evidence of a weak correlation with MMSE (r =-0.22, P = 0.09). In contrast, greater rates of ventricular expansion were clearly correlated with worsening concurrent change on CDR-SB (r = 0.42, P < 0.01) and MMSE (r =-0.52, P < 0.01). Our data are consistent with a model of typical late onset Alzheimer's disease that has two main features: (i) dissociation between the rate of amyloid deposition and the rate of neurodegeneration late in life, with amyloid deposition proceeding at a constant slow rate while neurodegeneration accelerates and (ii) clinical symptoms are coupled to neurodegeneration not amyloid deposition. Significant plaque deposition occurs prior to clinical decline. The presence of brain amyloidosis alone is not sufficient to produce cognitive decline, rather, the neurodegenerative component of Alzheimer's disease pathology is the direct substrate of cognitive impairment and the rate of cognitive decline is driven by the rate of neurodegeneration. Neurodegeneration (atrophy on MRI) both precedes and parallels cognitive decline. This model implies a complimentary role for MRI and PIB imaging in Alzheimer's disease, with each reflecting one of the major pathologies, amyloid dysmetabolism and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts continue to be placed on the early detection of AD as changes in brain chemistry begin to occur 20 years or more prior to the onset of noticeable cognitive symptoms [137,138,139,140].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although these symptoms are new to the individual affected, the brain changes that cause them are thought to begin 20 years or more before symptoms start.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies of non-demented elderly cohorts overall report approximately 20–40% are PIB-positive [67, 68, 71–78].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · cited 1×
“The automated anatomic labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002) was modified in-house to contain the following labelled regions of interest: right and left parietal, temporal, prefrontal, primary sensory -motor, orbito frontal, anterior cingulate, posterior cingulate/ precuneus and occipital.”
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citation
Cited by
Items 601–700 of 1,000
Molecular Imaging of Alzheimer Disease Pathology
Kantarci, K. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3847 · Cited by 28
Badachhape, A., Working, P. K., Srivastava, M., Bhandari, P., Stupin, I. V., Devkota, L., Tanifum, E. A., Annapragada, A., & Ghaghada, K. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-73233-7 · Cited by 25
Cai, Y., Fan, X., Zhao, L., Liu, W., Luo, Y., Lau, A. Y. L., Au, L. W. C., Shi, L., Lam, B. Y. K., Ko, H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13083 · Cited by 25
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
Spitzer, P., Klafki, H., Blennow, K., Buée, L., Esselmann, H., Herukka, S., Jiménez, C. R., Klivènyi, P., Lewczuk, P., Maler, J. M., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/548145 · Cited by 30
Harper, D. J., Augustin, M., Lichtenegger, A., Gesperger, J., Himmel, T., Muck, M., Merkle, C. W., Eugui, P., Kummer, S., Wöehrer, A., et al. (2020) · Neurophotonics · doi:10.1117/1.nph.7.1.015006 · Cited by 25
Marner, L., Knudsen, G. M., Madsen, K., Holm, S., Baaré, W. F. C., & Hasselbalch, S. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100903 · Cited by 26
How donanemab data address the coverage with evidence development questions
Klein, E. G., Schroeder, K. M., Wessels, A. M., Phipps, A., Japha, M., Schilling, T., & Zimmer, J. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13700 · Cited by 25
McGeachan, R. I., Meftah, S., Taylor, L. W., Catterson, J. H., Negro, D., Bonthron, C., Holt, K., Tulloch, J., Rose, J. L., Gobbo, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58879-z · Cited by 26
Cody, K. A., Koscik, R. L., Erickson, C. M., Berman, S. E., Jonaitis, E. M., Williams, V. J., Mueller, K. D., Christian, B. T., Chin, N. A., Clark, L. R., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12351 · Cited by 25
Hu, X., Meier, M., & Pruessner, J. C. (2023) · Brain and Behavior · doi:10.1002/brb3.2925 · Cited by 24
Examining the Bidirectional Nature of Loneliness and Anxiety Among Older Adults in Daily Life
Bogart, K. V., Scott, S., Harrington, K., Felt, J. M., Sliwinski, M. J., & Graham‐Engeland, J. E. (2023) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbad105 · Cited by 25
Leucocyte telomere length, brain volume and risk of dementia: a prospective cohort study
Cao, Z., Hou, Y., & Xu, C. (2023) · General Psychiatry · doi:10.1136/gpsych-2023-101120 · Cited by 26
High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain
Samaroo, H., Opsahl, A., Schreiber, J., O'Neill, S., Marconi, M., Qian, J., Carvajal‐Gonzalez, S., Tate, B. A., Milici, A. J., Bales, K. R., et al. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.003 · Cited by 25
Role of Copper and Cholesterol Association in the Neurodegenerative Process
Arnal, N., Morel, G. R., de Alaniz, M. J. T., Castillo, O., & Marra, C. A. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/414817 · Cited by 25
Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector
Zhao, W., Zhang, J., Davis, E. G., & Rebeck, G. W. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00210 · Cited by 25
Pimentel, L. S. B., Allard, S. T. M., Carmo, S. D., Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B. H., & Cuello, A. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143126 · Cited by 26
Sutoko, S., Masuda, A., Kandori, A., Sasaguri, H., Saito, T., Saido, T. C., & Funane, T. (2021) · iScience · doi:10.1016/j.isci.2021.102198 · Cited by 24
Fu, H., Huang, H., Liao, S., & Dai, Z. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1637029 · Cited by 24
Insulin resistance, type 2 diabetes, and AD: Cerebrovascular disease or neurodegeneration?
Luchsinger, J. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eee287 · Cited by 23
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
Rafii, M. S. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22658 · Cited by 24
Huang, C., Hsu, S., Tsai, S., Chen, N.-C., Liu, M., Lee, C., Huang, S., Chang, W.-N., Chang, Y., Tsai, W., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0791-z · Cited by 24
Smith, G. S., Protas, H., Kuwabara, H., Savonenko, A., Nassery, N., Gould, N. F., Kraut, M., Avramopoulos, D., Holt, D., Dannals, R. F., et al. (2023) · NeuroImage: Clinical · doi:10.1016/j.nicl.2023.103322 · Cited by 22
Unveiling Molecular Events in the Brain by Noninvasive Imaging
Klohs, J., & Rudin, M. (2011) · The Neuroscientist · doi:10.1177/1073858410383433 · Cited by 22
Blood β‐synuclein is related to amyloid PET positivity in memory clinic patients
Oeckl, P., Blūma, M., Bucci, M., Halbgebauer, S., Chiotis, K., Matton, A., Ashton, N. J., Molfetta, G. D., Grötschel, L., Kivipelto, M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13046 · Cited by 23
Jain, L., Khrestian, M., Formica, S. V., Tuason, E. D., Pillai, J. A., Rao, S. M., Oguh, O., Lippa, C. F., López, O. L., Berman, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13398 · Cited by 22
Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers’ Risk of Alzheimer’s Disease
Mosconi, L., & McHugh, P. F. (2015) · Current Nutrition Reports · doi:10.1007/s13668-014-0111-5 · Cited by 26
Rinne, J. O., Frantzén, J., Leinonen, V., Lönnrot, K., Laakso, A., Virtanen, K. A., Solin, O. H., Kotkansalo, A., Koivisto, A. M., Sajanti, J., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000355256 · Cited by 24
Melzer, T. R., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Watts, R., Keenan, R. J., Dalrymple‐Alford, J. C., & Anderson, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143923 · Cited by 22
Circadian Rhythms Disturbances in Alzheimer Disease: Current Concepts, Diagnosis, and Management
Milán-Tomás, Á., & Shapiro, C. M. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000243 · Cited by 25
Sopina, L., & Sørensen, J. R. (2018) · Health Economics Review · doi:10.1186/s13561-018-0192-8 · Cited by 22
Armbrust, F., Bickenbach, K., Marengo, L., Pietrzik, C. U., & Becker‐Pauly, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119164 · Cited by 22
Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients
Béliveau, É., Tremblay, C., Aubry-Lafontaine, É., Paris‐Robidas, S., Delay, C., Robinson, C. A., Ferguson, L., Rajput, A. H., Rajput, A. H., & Calon, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.016 · Cited by 23
Cognitive Decline and Amyloid Accumulation in Patients with Mild Cognitive Impairment
Koivunen, J., Karrasch, M., Scheinin, N. M., Aalto, S., Vahlberg, T. J., Någren, K., Helin, S., Viitanen, M. H., & Rinne, J. O. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341580 · Cited by 24
Mild cognitive impairment and on to dementia: Down the slippery slope but faster
Knopman, D. S. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5dc61 · Cited by 21
Self-citationMolecular Neuroimaging in Alzheimer's Disease
Matsuda, H., & Imabayashi, E. (2011) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.005 · Cited by 22
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Eisenmenger, L. B., Huo, E. J., Hoffman, J. M., Minoshima, S., Matesan, M. C., Lewis, D. H., Lopresti, B. J., Mathis, C. A., Okonkwo, D. O., & Mountz, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.003 · Cited by 26
A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease
Harenbrock, J., Holling, H., Reid, G., & Koychev, I. G. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100068 · Cited by 24
Chen, S., Zhang, D., Zheng, H., Cao, T., Xia, K., Su, M., & Meng, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1232941 · Cited by 21
Anesthesiology Must Play a Greater Role in Patients with Alzheimer's Disease
SILBERT, B. S., Evered, L. A., Scott, D. A., & Maruff, P. T. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182147f5b · Cited by 21
Schreiner, S. J., Liu, X., Gietl, A. F., Wyss, M., Steininger, S. C., Gruber, E., Treyer, V., Meier, I. B., Kälin, A. M., Leh, S. E., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00240 · Cited by 24
O3‐06‐05: LONGITUDINAL COGNITIVE DECLINE IN THE AIPL COHORT: THE ROLE OF APOE ɛ4 STATUS
Foster, J. K., Albrecht, M. A., Szoeke, C. E. I., Maruff, P. T., Savage, G. R., Lautenschlager, N. T., Ellis, K. A., Taddei, K., Martins, R. N., Masters, C. L., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.303 · Cited by 21
Lim, Y. Y., Villemagne, V. L., Laws, S. M., Pietrzak, R. H., Ames, D. J., Fowler, C. J., Rainey‐Smith, S. R., Snyder, P. J., Bourgeat, P., Martins, R. N., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0822-8 · Cited by 21
Hagenaars, S. P., Radaković, R., Crockford, C., Fawns‐Ritchie, C., Harris, S. E., Galé, C. R., & Deary, I. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198187 · Cited by 23
Canário, N., Jorge, L., Martins, R., Santana, I. J., & Castelo-Branco, M. S. (2022) · Communications Biology · doi:10.1038/s42003-022-03761-7 · Cited by 21
Roy, M., Cardoso, C., Dorieux, O., Malgorn, C., Epelbaum, S., Petit, F., Kraska, A., Brouillet, E., Delatour, B., Perret, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.017 · Cited by 22
Identifying combinatorial biomarkers by association rule mining in the CAMD Alzheimer's database
Szalkai, B., Grolmusz, V. K., & Grolmusz, V. I. (2017) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.08.006 · Cited by 21
Jiménez-Bonilla, J. F., Banzo, I., de Arcocha-Torres, M., Quirce, R., Martínez‐Rodríguez, I., Sánchez‐Juan, P., & CARRIL, J. M. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000934 · Cited by 22
Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
Fleisher, A., Donohue, M., Chen, K., Brewer, J. B., Aisen, P. S. S., & Initiative, T. A. D. N. (2009) · Behavioural Neurology · doi:10.1155/2009/836437 · Cited by 22
Femminella, G. D., Initiative, T. A. D. N., Taylor‐Davies, G., Scott, J., & Edison, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180365 · Cited by 20
Senthilkumar, T., Kumarganesh, S., Sivakumar, P., & Periyarselvam, K. (2022) · Journal of Intelligent & Fuzzy Systems · doi:10.3233/jifs-220628 · Cited by 23
RetractedExperimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 20
Paitel, E. R., & Nielson, K. A. (2023) · Psychophysiology · doi:10.1111/psyp.14395 · Cited by 21
Hashmi, M. U., Ahmed, R., Mahmoud, S., Ahmed, K., Bushra, N. M., Ahmed, A., Elwadie, B., Madni, A., Saad, A. B., & Abdelrahman, N. G. (2023) · Cureus · doi:10.7759/cureus.46732 · Cited by 24
Kelley, C. M., Perez, S. E., Overk, C., Wynick, D., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102097 · Cited by 21
Perception-related EEG is more sensitive to Alzheimer's disease effects than resting EEG
Barzegaran, E., DAMME, B. V., Meuli, R. A., & Knyazeva, M. G. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.032 · Cited by 21
the German AgeGain study group, Wolf, D. G. F., Tüscher, O., Teipel, S. J., Mierau, A., Strüder, H. K., Drzezga, A. E., Baier, B., Binder, H., & Fellgiebel, A. (2018) · Trials · doi:10.1186/s13063-018-2688-2 · Cited by 21
Duarte-Abritta, B., Villarreal, M. F., Abulafia, C., Loewenstein, D., Curiel, R. E., Castro, M. N., Surace, E. I., Sánchez, S. M., Vigo, D. E., Vázquez, S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.10.008 · Cited by 21
Reas, E. T., Hagler, D. J., Kuperman, J. M., Wierenga, C. E., Galasko, D. R., White, N. S., Dale, A. M., Banks, S. J., McEvoy, L. K., & Brewer, J. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190871 · Cited by 20
Jorge, L., Martins, R., Canário, N., Xavier, A. C., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200840 · Cited by 22
Higuchi, M., Maeda, J., Ji, B., Maruyama, M., Okauchi, T., Tokunaga, M., Ono, M., & Suhara, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.003 · Cited by 20
The Precuneus – A Witness for Excessive Aβ Gathering in Alzheimer’s Disease Pathology
Aghakhanyan, G., Vergallo, A., Gennaro, M., Mazzarri, S., Guidoccio, F., Radicchi, C., Ceravolo, R., Tognoni, G., Bonuccelli, U., & Volterrani, D. (2018) · Neurodegenerative Diseases · doi:10.1159/000492945 · Cited by 20
Meyer, P., McSweeney, M., Gonneaud, J., & Villeneuve, S. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.001 · Cited by 22
Chang, C., Chang, Y., Huang, C., Tsai, S., Hsu, S., Huang, S., Lee, C., Chang, W., Lui, C., & Lien, C.-Y. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0344-4 · Cited by 20
Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J., & Yahaya, M. F. (2023) · Antioxidants · doi:10.3390/antiox12020427 · Cited by 19
Alzheimer′s disease: Unique markers for diagnosis & new treatment modalities
Aggarwal, N. T., Shah, R. C., & Bennett, D. A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.169193 · Cited by 30
Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins
Ułamek-Kozioł, M., Pluta, R. M., Bogucka‐Kocka, A., Januszewski, S., Kocki, J., & Czuczwar, S. J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.01.006 · Cited by 20
Kosenko, E. A., Tikhonova, L. A., Alilova, G. A., Urios, A., & Montoliu, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010206 · Cited by 21
Imaging the aging brain: study design and baseline findings of the SENIOR cohort
Haeger, A., Mangin, J., Vignaud, A., Poupon, C., Grigis, A., Boumezbeur, F., Frouin, V., Deverre, J.-R., Sarazin, M., Hertz‐Pannier, L., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00642-1 · Cited by 23
Effects of Homocysteine on white matter diffusion parameters in Alzheimer’s disease
Lee, C., Hsu, S., Huang, C., Chang, W., Chen, S.-F., Wu, M., Chang, C., Hwang, L.-C., & Chen, P.-C. (2017) · BMC Neurology · doi:10.1186/s12883-017-0970-7 · Cited by 19
Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline
Martikainen, I. K., Kemppainen, N. M., Johansson, J. J., Teuho, J., Helin, S., Liu, Y., Helisalmi, S., Soininen, H. S., Parkkola, R. K., Ngandu, T., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5891 · Cited by 20
Han, F., Xu, H., Shen, J.-X., Pan, C., Yu, Z.-H., Chen, J.-J., Zhu, X.-L., Cai, Y.-F., & Lu, Y.-P. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-021 · Cited by 18
“A number of studies have revealed that AD under‐ goes a progressive lesion process and is thought to be‐ gin 20 years or more before symptoms arise, with small changes in the brain (Jack et al., 2009; Heiko et al., 2011; Bateman et al., 2012; Reiman et al., 2012; Villemagne et al., 2013; Gordon et al., 2018).”
BackgroundTrajectory of clinical symptoms in relation to amyloid chronicity
Birdsill, A. C., Koscik, R. L., Cody, K. A., Jonaitis, E. M., Cadman, R. V., Erickson, C. M., Chin, N. A., Przybelski, R. J., Carlsson, C. M., Asthana, S., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12360 · Cited by 18
Grid-tuned ensemble models for 2D spectrogram-based autism classification
Ullah, M. Z., & Yu, D. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106151 · Cited by 22
Advances in molecular imaging for the diagnosis of dementia
Okamura, N., Fodero‐Tavoletti, M. T., Kudo, Y., Rowe, C. C., Furumoto, S., Arai, H., Masters, C. L., Yanai, K., & Villemagne, V. L. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903133790 · Cited by 19
A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin‐D detection
Ta, R. M., Suchý, M., Tam, J. H. K., Li, A. X., Martínez‐Santiesteban, F., Scholl, T. J., Hudson, R. H. E., Bartha, R., & Pasternak, S. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1502 · Cited by 20
Ward, D. D., Andel, R., Saunders, N. L., Thow, M. E., Klekociuk, S. Z., Bindoff, A. D., & Vickers, J. C. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.04.006 · Cited by 19
Skoog, I. G., Kern, S., Zetterberg, H., Östling, S., Börjesson‐Hanson, A., Guo, X., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170950 · Cited by 20
Amyloid imaging: Coming to a PET scanner near you
Jagust, W. J. (2010) · Annals of Neurology · doi:10.1002/ana.22144 · Cited by 18
Collij, L. E., Mastenbroek, S. E., Salvadó, G., Wink, A. M., Visser, P. J., Barkhof, F., van Berckel, B. N. M., & Lopes Alves, I. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12216 · Cited by 17
Timofeeva, A. M., Aulova, K. S., & Nevinsky, G. A. (2025) · Brain Sciences · doi:10.3390/brainsci15050486 · Cited by 17
Longitudinal Amyloid-β PET in Atypical Alzheimer’s Disease and Frontotemporal Lobar Degeneration
Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Graff‐Radford, J., Duffy, J. R., Clark, H. M., Machulda, M. M., Botha, H., Utianski, R. L., Schwarz, C. G., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190699 · Cited by 17
Self-citationZhao, Q. X., Du, X., Chen, W., Zhang, T., & Xu, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1216215 · Cited by 19
Emerging Biomarkers in Cognition
Wicklund, M. R., & Petersen, R. C. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.006 · Cited by 19
Self-citationPractical algorithms for amyloid β probability in subjective or mild cognitive impairment
Maserejian, N. N., Bian, S., Wang, W., Jaeger, J., Syrjanen, J. A., Aakre, J. A., Jack, C. R., Mielke, M. M., & Gao, F. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.09.001 · Cited by 18
Self-citationLi, L., Ma, Y., Bi, Y., Sun, F.-R., Hu, H., Hou, X., Xu, W., Shen, X., Dong, Q., Tan, L., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201192 · Cited by 17
Kumar, A., Janelidze, S., Stomrud, E., Palmqvist, S., Hansson, O., Mattsson, N., & Initiative, A. D. N. (2022) · Neurology · doi:10.1212/wnl.0000000000200605 · Cited by 17
Kulminski, A. M., Initiative, A. D. N., Jain‐Washburn, E., Loiko, E., Loika, Y., Feng, F., & Culminskaya, I. V. (2022) · Aging · doi:10.18632/aging.204384 · Cited by 19
Brier, M. R., McCarthy, J. E., Benzinger, T. L. S., Stern, A., Su, Y., Friedrichsen, K. A., Morris, J. C., Ances, B. M., & Vlassenko, A. G. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.025 · Cited by 17
Fjell, A. M., & Walhovd, K. B. (2011) · The Neuroscientist · doi:10.1177/1073858410392586 · Cited by 19
Gardner, M. R., Baruah, V., Vargas, G., Motamedi, M., Milner, T. E., & Rylander, H. G. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.5.18 · Cited by 17
Molecular Brain Imaging in the Multimodality Era
Price, J. C. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.29 · Cited by 18
Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB‐PET Threshold
Ismail, R., Parbo, P., Hansen, K. V., Schaldemose, J. L., Dalby, R. B., Tietze, A., Kjeldsen, P. L., la Cour, S. H., Qvist, P., Gottrup, H., et al. (2019) · Journal of Neuroimaging · doi:10.1111/jon.12629 · Cited by 16
Cost Effective Community Based Dementia Screening: A Markov Model Simulation
Saito, E. K., Nakamoto, B. K., Mendez, M. F., Mehta, B. K., & McMurtray, A. M. (2014) · International Journal of Alzheimer s Disease · doi:10.1155/2014/103138 · Cited by 17
Amyloid + Activation = Alzheimer's?
Jagust, W. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.008 · Cited by 18
Kim, Y., Lee, H. J., Son, T. O., Jang, H., Cho, S. H., Kim, S. E., Kim, S. J., Lee, J. S., Kim, J. P., Jung, Y. H., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102140 · Cited by 16
Insights into cognitive aging and Alzheimer’s disease using amyloid PET and structural MRI scans
Duara, R., Barker, W., Loewenstein, D., Greig, M. T., Rodriguez, R. A., Goryawala, M., Zhou, Q., & Adjouadi, M. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0110-6 · Cited by 16
Impact of nano-conjugate on Drosophila for early diagnosis of Alzheimer’s disease
Ahmed, A. R., Ghallab, E. H., Shehata, M., Zekri, A. N., & Ahmed, O. S. (2020) · Nanotechnology · doi:10.1088/1361-6528/ab7535 · Cited by 15
Thiophene‐Based Optical Ligands That Selectively Detect Aβ Pathology in Alzheimer's Disease
Klingstedt, T., Shirani, H., Ghetti, B. F., Vidal, R., & Nilsson, K. P. R. (2021) · ChemBioChem · doi:10.1002/cbic.202100199 · Cited by 17
New Horizons—Cognitive Dysfunction Associated With Type 2 Diabetes
Moran, C., Than, S., Callisaya, M. L., Beare, R. J., & Srikanth, V. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab797 · Cited by 17
Amyloid-β accumulation in relation to functional connectivity in aging: A longitudinal study
Liu, G., Shen, C., & Qiu, A. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120146 · Cited by 16
Metadata
- Authors
- Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., Weiner, M., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Jack, Clifford R.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-31
- Volume
- 132
- Issue
- 5
- Pages
- 1355-1365
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2677798
- OpenAlex
- W2133719476
- Cited by
- 1,099
- References
- 83
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 34 · 2023: 51 · 2022: 45 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 62 · 2017: 46 · 2016: 56 · 2015: 69 · 2014: 73 · 2013: 94 · 2012: 116
- FWCI
- 71.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Mayo Foundation for Medical Education and Research (AG16574)
- National Institute for Health and Care Research (NF-SI-0508-10123)
- National Institute on Aging (R01AG11378, P01AG010491, P50‐AG16574, U01AG06786, AG 024904, R01AG027342, U01AG006786, R01AG011378, P30AG019610, U19AG010483, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, mild cognitive impairment, amyloid deposition, neurodegeneration, brain atrophy, ventriculomegaly, Pittsburgh compound B PET, serial imaging, amyloid plaques, cognitive decline, Alzheimer's Disease Neuroimaging Initiative, brain atrophy rate
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Thiazoles, Time Factors, Case-Control Studies, Amyloid beta-Peptides, Statistics, Nonparametric, Radiopharmaceuticals, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.